- CSR in Takeda
- Support for Areas Affected by the Great East Japan Earthquake
- CSR Activities and Targets
- ISO 26000 Core Subjects
- Organizational Governance
- Human Rights
- Labor Practices
- The Environment
- Fair Operating Practices
- Consumer Issues
- Community Involvement and Development
- Policies
- Reports
- CSR Data Book Survey
>NEWSROOM
>October - December 2008
>Notice of Execution of Acquisition of the Company's Own Shar...
October - December 2008
October 17, 2008
Takeda Pharmaceutical Company Limited
Notice of Execution of Acquisition of the Company's Own Shares
Osaka, Japan, October 17, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on September 25, 2008.
| 1. Class of shares acquired: | Shares of common stock |
|---|---|
| 2. Period of acquisition: | From October 1, 2008 to October 15, 2008 |
| 3. Total number of shares acquired: | 9,000,000 shares |
| 4. Total value of acquisition: | Yen 47,649,334,000 |
| 5. Method of acquisition: | Purchased on the Tokyo Stock Exchange |
(Reference)
Resolution of the Board of Directors on September 25, 2008
| 1. Class of shares to be acquired: | Shares of common stock |
|---|---|
| 2. Number of shares to be acquired: | Up to 9 million shares (equivalent to 1.10% of the total issued shares) |
| 3. Total amount of shares to be acquired: | Up to 50 billion Yen |
| 4. Schedule of acquisition: | From October 1, 2008 to October 24, 2008 |
Treasury shares held by Takeda as of October 15, 2008
| 1. Aggregate number of issued shares: (excluding treasury shares) |
805,937,030 shares |
| 2. Number of treasury shares: | 9,215,365 shares |
# # #
Latest News Release
Copyright © 1995-2013 Takeda Pharmaceutical Company Limited. All rights reserved.